AlloVir, Inc. (ALVR)
NASDAQ: ALVR · Real-Time Price · USD
0.404
-0.046 (-10.22%)
At close: Dec 20, 2024, 4:00 PM
0.419
+0.015 (3.71%)
After-hours: Dec 20, 2024, 6:51 PM EST
AlloVir Market Cap
AlloVir has a market cap or net worth of $46.24 million as of December 20, 2024. Its market cap has decreased by -81.83% in one year.
Market Cap
46.24M
Enterprise Value
-75.62M
1-Year Change
-81.83%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since July 30, 2020, AlloVir's market cap has decreased from $1.43B to $46.24M, a decrease of -96.77%. That is a compound annual growth rate of -54.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 46.24M | -38.54% |
| Dec 29, 2023 | 75.22M | -83.78% |
| Dec 30, 2022 | 463.83M | -42.20% |
| Dec 31, 2021 | 802.46M | -66.14% |
| Dec 31, 2020 | 2.37B | 65.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VolitionRx | 53.84M |
| Mural Oncology | 53.63M |
| Serina Therapeutics | 51.98M |
| MAIA Biotechnology | 51.68M |
| LakeShore Biopharma | 51.52M |
| Invivyd | 51.40M |
| Reviva Pharmaceuticals Holdings | 50.16M |
| Singular Genomics Systems | 50.08M |